Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-118
CJC-1295 + Ipamorelin 5mg + 5mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-118
Active Batch Lot
GH Secretagogues & Growth Factors • In stock — Ready to ship

CJC-1295 + Ipamorelin (5mg + 5mg)

€62 5mg + 5mg • EUR

Dual-receptor somatotropic research blend combining 5 mg CJC-1295 No DAC (GHRH-R) with 5 mg Ipamorelin (selective GHS-R1a) for investigating synergistic cAMP and PLC/Ca²⁺ growth hormone release kinetics.

Chemical & Registry Specifications
CAS Registry Number 863288-34-0 / 170851-70-4
Molecular Formula C152H252N44O42 + C38H49N9O5
Molecular Weight 3367.97 g/mol & 711.86 g/mol
Counterion / Form Acetate lyophilized blend
Sequence / Structural Class Co-lyophilized Mod GRF(1-29) + Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
Primary Biological Target / Pathway Dual Pituitary GHRH-R & GHS-R1a (Ghrelin Receptor)
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: CJC-1295 + Ipamorelin

Dual-receptor somatotropic research blend combining 5 mg CJC-1295 No DAC (GHRH-R) with 5 mg Ipamorelin (selective GHS-R1a) for investigating synergistic cAMP and PLC/Ca²⁺ growth hormone release kinetics.

Verified 1:1 co-lyophilized dual-pathway secretagogue blend
Zero cortisol, ACTH, or prolactin cross-activation profile
Dual-peak RP-HPLC verification certificate per batch
Primary Literature Reference Raun K. et al., Eur J Endocrinol (1998) — Selective GHS-R1a agonism of Ipamorelin without ACTH/cortisol elevation (PMID: 9849822)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-118)

Analytical release verification for current CJC-1295 + Ipamorelin (5mg + 5mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-118 2026-10-28 Gradient RP-HPLC (Multi-Peak Resolution) + ESI-MS ≥99.0% (Resolved Constituent Peaks) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water (2.0 mL)

Temperature & Stability

Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 28 days.

CJC-1295 + Ipamorelin — Technical Questions & Answers

How are the individual constituents of CJC-1295 + Ipamorelin verified in a single vial?

Because co-lyophilized blends contain multiple sequences with distinct retention times, Lot SL-2026-118 is evaluated via gradient RP-HPLC to resolve each constituent peak independently, paired with ESI-MS mass confirmation (3367.97 g/mol & 711.86 g/mol).

How do you calculate working stock aliquots for a multi-component blend like CJC-1295 + Ipamorelin?

Calculate each active constituent separately based on its labeled mass ratio (5mg + 5mg) divided by total diluent volume added. For example, adding 2.0 mL of sterile diluent yields proportional mg/mL concentrations for every component simultaneously.

What primary pathways are investigated using CJC-1295 + Ipamorelin?

Investigators study CJC-1295 + Ipamorelin in Dual Pituitary GHRH-R & GHS-R1a (Ghrelin Receptor) models. Primary published literature context: Raun K. et al., Eur J Endocrinol (1998) — Selective GHS-R1a agonism of Ipamorelin without ACTH/cortisol elevation (PMID: 9849822). All lots are supplied strictly for in-vitro laboratory experimentation.

Research Use Only (RUO): CJC-1295 + Ipamorelin is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related GH Secretagogues & Growth Factors Compounds

View category →
≥99.0%
ACE-031 1 mg — ≥99.0% Research Vial
ACE-031
1 mg In stock
CAS 1169766-01-1
MW: ~79.0 kDa (homodimer)
€75
≥99.0%
CJC-1295 5 mg — ≥99.0% Research Vial
CJC-1295
5 mg In stock
CAS 863288-34-0 (with DAC)
MW: 3647.28 g/mol
€48
≥99.0%
Follistatin 1 mg — ≥99.0% Research Vial
Follistatin
1 mg In stock
CAS 117628-82-7
MW: ~34.8 kDa (non-glycosylated core)
€82

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog